A case study making the rounds on social media outlines how a woman injected with the Wuhan coronavirus (COVID-19) vaccine from AstraZeneca developed psychosis post-vaccination.
The case study published January 2022 in Schizophrenia Research touched on an 18-year-old female student who was sent to the hospital for “irrelevant talk and bizarre behavior.” According to the paper, she had no history of physical illness or substance use. In fact, she had been perfectly healthy both physically and mentally before getting injected.
“While there have been numerous pieces of medical literature on the neurological side effects of the COVID-19 vaccinations, they often revolve around more physical ailments such as lethal headaches and seizures, paralysis, Bell’s palsy, Alzheimer’s [disease], Parkinson’s [disease] and Guillain-Barre syndrome (GBS),” the case study noted, adding that the psychotic behavior exhibited by the woman would be classified within the category of neurological side effects.
“Over the period of [the] last few weeks, some of the serious side effects with various (COVID-19) vaccines have been documented in the form of GBS. There is limited data with respect to the psychiatric side effects of the COVID-19 vaccine. Few case reports have documented new onset psychosis after the use of messenger-ribonucleic acid (mRNA) based COVID-19 vaccines.” (Related: The CONNECTION between AUTISM and COVID JABS could boil down to destruction of good gut bacteria.)
The researchers ultimately noted in their case study that “considering the limited data, in this report we present a case of new onset psychosis, following the use of [the] Covishield vaccine.” Covishield is the local version of the Anglo-Swedish pharmaceutical firm’s vaccine, manufactured and marketed by the Serum Institute of India.
Hellbound and Down 